Targeting Cell Cycle to Suppress Cancer Aggressiveness

Author(s): Jayalaxmi Shetty, Iekhsan Othman, Anuar Zaini, Ezharul Hoque Chowdhury*

Journal Name: Current Signal Transduction Therapy

Volume 12 , Issue 2 , 2017

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Background: Failure of cell division control due to mutations leading to inactivation or over activation of regulatory proteins is the leading cause of cancer development. Several mitogens and growth factors have been found to regulate cancer cell cycle progression. However, all signalling pathways converge to the cell cycle machinery and thus disruption of cell cycle control offers an attractive therapeutic target for the treatment of cancer.

Method: We undertook a comprehensive search of bibliographic databases through PubMed and selected the most relevant and appropriate peer-reviewed research articles.

Results: There has been a breakthrough in identification of the cell cycle regulatory molecules and elucidation of their roles in subtle adjustment of the balance between proliferation and apoptosis of cancer cells. This review will shed light on the current understanding of the regulation of the cell cycle pathway links and the feasibility of targeting cell cycle for fighting metastatic cancer.

Conclusion: There are cross-talks among the diverse neoplastic cell types acting together on cell cycle to ensure survival, growth and metastasis, by inhibiting apoptosis, promoting angiogenesis, and avoiding immune system. Approaches should be undertaken to synergistically block the activation of the interconnected pathways for effective cancer therapy.

Keywords: Cancer, drug targets, cell cycle, metabolic reprogramming, oxidative stress, immunomodulatory microRNAs, extraribosomal functions, CDK, cyclins, genomic instability, check points, p53, therapeutics.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Published on: 22 February, 2018
Page: [85 - 115]
Pages: 31
DOI: 10.2174/1574362412666170330145949
Price: $65

Article Metrics

PDF: 30
PRC: 1